One Zyme
4 known investors
One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
AI & Machine LearningBiotechEnterprise Software
Founders & leadership
AM
Investors Β· 4
Frequently asked questions
- What does One Zyme do?
- One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
- Who founded One Zyme?
- One Zyme was founded by Aaron Michel.
- Who are One Zyme's investors?
- One Zyme's investors include Invariantes Fund, Newfund Capital, Service Provider Capital, TMV.